These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17702584)

  • 1. Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma.
    Goldberg R; Drummond KJ
    J Clin Neurosci; 2008 Oct; 15(10):1164-6. PubMed ID: 17702584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients.
    Felfernig M; Huepfl M
    Clin Neurol Neurosurg; 2008 Mar; 110(3):227-32. PubMed ID: 18083302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.
    Sniecinski RM; Chen EP; Levy JH; Szlam F; Tanaka KA
    Anesth Analg; 2007 Apr; 104(4):763-5. PubMed ID: 17377078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature.
    Haan J; Scalea T
    Am Surg; 2005 May; 71(5):414-5. PubMed ID: 15986972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation.
    Jabbour N; Gagandeep S; Peilin AC; Boland B; Mateo R; Genyk Y; Selby R; Zeger G
    Am Surg; 2005 Feb; 71(2):175-9. PubMed ID: 16022020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma.
    Veshchev I; Elran H; Salame K
    Med Sci Monit; 2002 Dec; 8(12):CS98-100. PubMed ID: 12503044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding.
    Kandane-Rathnayake RK; Isbister JP; Zatta AJ; Aoki NJ; Cameron P; Phillips LE;
    ANZ J Surg; 2013 Mar; 83(3):155-60. PubMed ID: 23035873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.
    Bolliger D; Sreeram G; Duncan A; Molinaro RJ; Szlam F; Chen EP; Tanaka KA
    Ann Thorac Surg; 2009 Nov; 88(5):1666-8. PubMed ID: 19853132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux.
    Bordes J; Asencio Y; Kenane N; Fesselet J; Meaudre E; Goutorbe P
    Br J Anaesth; 2008 Oct; 101(4):575-6. PubMed ID: 18782890
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of recombinant activated factor VII in a Jehovah's Witness patient.
    Hsieh A; Cheong I
    Am J Emerg Med; 2007 Nov; 25(9):1085.e1-2. PubMed ID: 18022514
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
    Veneri D; Franchini M
    Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.
    Chigbu B; Onwere S; Kamanu C; Aluka C; Okoro O; Feyi-Waboso P; Onichakwe C
    Arch Gynecol Obstet; 2009 Apr; 279(4):469-72. PubMed ID: 18677500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings.
    Lin J; Hanigan WC; Tarantino M; Wang J
    J Neurosurg; 2003 Apr; 98(4):737-40. PubMed ID: 12691397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beriplex P/N: an alternative to fresh frozen plasma in severe haemorrhage.
    Bhardwaj M; Bunsell R
    Anaesthesia; 2007 Aug; 62(8):832-4. PubMed ID: 17635434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of and for the individual rather than the religious institution.
    Elder L
    Anesth Analg; 2007 Apr; 104(4):757-8. PubMed ID: 17377076
    [No Abstract]   [Full Text] [Related]  

  • 19. A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery.
    Chau A; Wu J; Ansermino M; Tredwell S; Purdy R
    Can J Anaesth; 2008 Jan; 55(1):47-51. PubMed ID: 18166748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.